Pacific Sun Financial’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,406
| Closed | -$216K | – | 186 |
|
|
2022
Q1 | $216K | Buy |
2,406
+36
| +2% | +$3.23K | 0.12% | 183 |
|
|
2021
Q4 | $265K | Buy |
2,370
+20
| +0.9% | +$2.24K | 0.14% | 160 |
|
|
2021
Q3 | $295K | Buy |
+2,350
| New | +$295K | 0.17% | 138 |
|
|
2020
Q3 | $262K | Buy |
2,350
+90
| +4% | +$10K | 0.22% | 125 |
|
|
2020
Q2 | $253K | Buy |
+2,260
| New | +$253K | 0.23% | 120 |
|
|
2020
Q1 | – | Sell |
-2,200
| Closed | -$209K | – | 142 |
|
|
2019
Q4 | $209K | Buy |
+2,200
| New | +$209K | 0.18% | 136 |
|
|
2018
Q2 | $201K | Buy |
+2,090
| New | +$201K | 0.21% | 124 |
|